Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin C Milgram

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Organic Letters|October 22, 2004
Efficient synthesis of acylsilanes using morpholine amidesChristopher T Clark, Benjamin C Milgram, Karl A Scheidt
Organic Letters|November 17, 2011
Gram-scale synthesis of the A'B'-subunit of angelmicin BBenjamin C Milgram, Brian B Liau, Matthew D Shair
Journal of the American Chemical Society|September 14, 2012
Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1Brian B Liau, Benjamin C Milgram, Matthew D Shair
Journal of the American Chemical Society|October 20, 2005
Catalytic conjugate additions of carbonyl anions under neutral aqueous conditionsMichael C Myers, Ashwin R Bharadwaj, Benjamin C Milgram, et al.
The Journal of Organic Chemistry|April 17, 2007
Microwave-assisted Piloty-Robinson synthesis of 3,4-disubstituted pyrrolesBenjamin C Milgram, Katrine Eskildsen, Steven M Richter, et al.
Organic Letters|January 13, 2023
Regioselective Synthesis of Fully Substituted Fused Pyrroles through an Oxidant-Free Multicomponent ReactionKonstantinos Afratis, Joseph M Bateman, Benjamin F Rahemtulla, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2022
Discovery of pyridyl urea sulfonamide inhibitors of Na<sub>V</sub>1.7John R Butler, Gwenaella Rescourio, Benjamin C Milgram, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2017
Discovery of a biarylamide series of potent, state-dependent Na<sub>V</sub>1.7 inhibitorsLaurie B Schenkel, Erin F DiMauro, Hanh N Nguyen, et al.
Journal of Medicinal Chemistry|January 17, 2025
Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung CancerBenjamin C Milgram, Deanna R Borrelli, Natasja Brooijmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsRaymond A Pagliarini, Jack A Henderson, Benjamin C Milgram, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Organic Letters|October 22, 2004
Efficient synthesis of acylsilanes using morpholine amidesChristopher T Clark, Benjamin C Milgram, Karl A Scheidt
Organic Letters|November 17, 2011
Gram-scale synthesis of the A'B'-subunit of angelmicin BBenjamin C Milgram, Brian B Liau, Matthew D Shair
Journal of the American Chemical Society|September 14, 2012
Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1Brian B Liau, Benjamin C Milgram, Matthew D Shair
Journal of the American Chemical Society|October 20, 2005
Catalytic conjugate additions of carbonyl anions under neutral aqueous conditionsMichael C Myers, Ashwin R Bharadwaj, Benjamin C Milgram, et al.
The Journal of Organic Chemistry|April 17, 2007
Microwave-assisted Piloty-Robinson synthesis of 3,4-disubstituted pyrrolesBenjamin C Milgram, Katrine Eskildsen, Steven M Richter, et al.
Organic Letters|January 13, 2023
Regioselective Synthesis of Fully Substituted Fused Pyrroles through an Oxidant-Free Multicomponent ReactionKonstantinos Afratis, Joseph M Bateman, Benjamin F Rahemtulla, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2022
Discovery of pyridyl urea sulfonamide inhibitors of Na<sub>V</sub>1.7John R Butler, Gwenaella Rescourio, Benjamin C Milgram, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2017
Discovery of a biarylamide series of potent, state-dependent Na<sub>V</sub>1.7 inhibitorsLaurie B Schenkel, Erin F DiMauro, Hanh N Nguyen, et al.
Journal of Medicinal Chemistry|January 17, 2025
Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung CancerBenjamin C Milgram, Deanna R Borrelli, Natasja Brooijmans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsRaymond A Pagliarini, Jack A Henderson, Benjamin C Milgram, et al.
Pageof 2